Oakland, CA, United States of America

Willieford Moses

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Willieford Moses: Innovator in Bioartificial Ultrafiltration Devices

Introduction

Willieford Moses is a prominent inventor based in Oakland, CA. He has made significant contributions to the field of bioengineering, particularly in the development of bioartificial ultrafiltration devices. With a total of 3 patents to his name, Moses is recognized for his innovative approaches to medical technology.

Latest Patents

Moses's latest patents include groundbreaking work on bioartificial ultrafiltration devices. These devices comprise a scaffold that contains a population of cells enclosed in a matrix, which is strategically positioned adjacent to multiple channels. The population of cells is designed to provide therapeutic molecules to subjects in need, supported by nutrients filtered from the subject's blood through ultrafiltration. The channels within the scaffold facilitate the transportation of ultrafiltrate and enable the exchange of molecules between the ultrafiltrate and the cell population.

Career Highlights

Willieford Moses is affiliated with the University of California, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve therapeutic delivery systems and enhance patient care.

Collaborations

Moses collaborates with notable colleagues such as Shuvo Roy and Rishi Kant, who contribute to the innovative projects he undertakes. Their combined expertise fosters a dynamic research environment that drives forward the field of bioengineering.

Conclusion

Willieford Moses stands out as a key figure in the development of bioartificial ultrafiltration devices. His innovative patents and collaborations reflect his commitment to advancing medical technology for better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…